Skip to content

Electrical Impedance Tomography (EIT) Monitoring in Adults With ALI or ARDS

Electrical Impedance Tomography (EIT) Monitoring: A Pilot Comparison to Standard of Care Assessments in Adults With Acute Lung Injury (ALI) or Acute Respiratory Distress Syndrome (ARDS)

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01272882
Enrollment
13
Registered
2011-01-10
Start date
2010-05-31
Completion date
2011-03-31
Last updated
2017-05-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute Lung Injury (ALI), ARDS

Brief summary

Electrical impedance tomography (EIT) monitoring has been researched as a method to determine the spatial impedance distribution in a body cross section, but has yet to become an established clinical tool. EIT monitoring gives a dynamic, breath-to-breath measurement of both global and regional ventilation. Recently, there has been evidence that EIT monitoring has great potential to become a non-invasive bedside tool for assessment of regional lung ventilation without documented hazards. Potential applications include any adult patients in acute respiratory failure. Data collected from this research may contribute to improved patient safety outcomes. PURPOSE: The purpose of this pilot study is to examine the feasibility of using the EIT monitor in intensive care unit (ICU) setting on patients with acute respiratory failure and to compare the EIT monitor data to standard of care patient assessments. It is hypothesized that the EIT monitor, when applied to adults in acute respiratory failure, will correlate with conventional standard of care assessments for these patients.

Detailed description

INTRODUCTION: Electrical impedance tomography (EIT) monitoring has been researched as a method to determine the spatial impedance distribution in a body cross section, but has yet to become an established clinical tool. EIT monitoring gives a dynamic, breath-to-breath measurement of both global and regional ventilation. Recently, there has been evidence that EIT monitoring has great potential to become a non-invasive bedside tool for assessment of regional lung ventilation without documented hazards. Potential applications include any adult patients in acute respiratory failure. Data collected from this research may contribute to improved patient safety outcomes. PURPOSE: The purpose of this pilot study is to examine the feasibility of using the EIT monitor in ICU setting on patients with acute respiratory failure and to compare the EIT monitor data to standard of care patient assessments. It is hypothesized that the EIT monitor, when applied to adults in acute respiratory failure, will correlate with conventional standard of care assessments for these patients. METHOD: This pilot study design will consist of a prospective, blinded evaluation of the EIT monitor for patients with acute lung injury or acute respiratory distress syndrome. Once a patient has met the inclusion criteria and has signed informed consent: 1. EIT electrode chest band will be applied by trained respiratory care staff. Application includes elastic chest band with 16 electrodes. 2. EIT electrode chest band is connected to the EIT monitor which will be turned on and will monitor and store EIT data. 3. EIT monitoring will take place for 4 to 6 hours, during day shift (7am to 4pm) 4. Patient's may be monitored on three separate days. No interventions, tests or modifications to the standard of care will occur to patients for this pilot study of EIT monitoring. Clinicians guiding the care of these patients will be blinded to the EIT data. The EIT chest band will be removed if transport of the patient is necessary or if care is needed in the area of the chest band.

Interventions

Chest belt with 16 electrodes connected to the EIT device

Sponsors

Christiana Care Health Services
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
BASIC_SCIENCE
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

Patients will be included in this study if the following criteria have been met: 1. Males and females \> 18 years old (non-pregnant, non-lactating females). 2. Partial pressure of arterial oxygen (PaO2) / Fraction of inspired oxygen (FiO2) ratio \< 300 torr. 3. Signed informed consent has been obtained.

Exclusion criteria

1. Females who are pregnant or lactating. 2. Patients with skin abrasions or wounds in the chest area. 3. Patients receiving dialysis. 4. Patients with pacemakers or paced EKG rhythms.

Design outcomes

Primary

MeasureTime frameDescription
Feasibility of EIT Monitoring in This Population of ARDS/ALI PatientsAt the start of monitoring once the patient was consented and enrolled.Feasibility for the purposes of our study was the ability to apply the device to a diverse population of ARDS/ALI patients and obtain EIT data from the device.

Countries

United States

Participant flow

Recruitment details

Intensive care units

Pre-assignment details

No pre-assignment details to note.

Participants by arm

ArmCount
Adults With ARDS or ALI
Adults with PaO2/FiO2 ratio less than 300. Electrical Impedance Tomography monitoring : Chest belt with 16 electrodes connected to the EIT device
13
Total13

Baseline characteristics

CharacteristicAdults With ARDS or ALI
Age, Categorical
<=18 years
0 Participants
Age, Categorical
>=65 years
0 Participants
Age, Categorical
Between 18 and 65 years
13 Participants
Age, Continuous55 years
STANDARD_DEVIATION 22
Region of Enrollment
United States
13 participants
Sex: Female, Male
Female
7 Participants
Sex: Female, Male
Male
6 Participants

Adverse events

Event typeEG000
affected / at risk
deaths
Total, all-cause mortality
— / —
other
Total, other adverse events
0 / 13
serious
Total, serious adverse events
0 / 13

Outcome results

Primary

Feasibility of EIT Monitoring in This Population of ARDS/ALI Patients

Feasibility for the purposes of our study was the ability to apply the device to a diverse population of ARDS/ALI patients and obtain EIT data from the device.

Time frame: At the start of monitoring once the patient was consented and enrolled.

ArmMeasureValue (NUMBER)
Adults With ARDS or ALIFeasibility of EIT Monitoring in This Population of ARDS/ALI Patients13 Patients successfully monitored with EIT

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026